PATIENT-CONTROLLED DOSE REGIMEN OF METHADONE FOR CHRONIC CANCER PAIN

被引：78

作者：

SAWE, J

HANSEN, J

GINMAN, C

HARTVIG, P

JAKOBSSON, PA

NILSSON, MI

RANE, A

ANGGARD, E

机构：

[1] UNIV UPPSALA HOSP,S-75014 UPPSALA,SWEDEN

[2] KAROLINSKA INST,S-10401 STOCKHOLM 60,SWEDEN

[3] ULLERAKER HOSP,PSYCHIAT RES CTR,S-75017 UPPSALA,SWEDEN

来源：

BRITISH MEDICAL JOURNAL | 1981年 / 282卷 / 6266期

关键词：

D O I：

10.1136/bmj.282.6266.771

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：771 / 773

页数：3

共 13 条

[1] PHARMACOKINETICS OF METHADONE DURING MAINTENANCE THERAPY - PULSE LABELING WITH DEUTERATED METHADONE IN THE STEADY-STATE [J].

ANGGARD, E ;

NILSSON, MI ;

HOLMSTRAND, J ;

GUNNE, LM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) :53-57

[2]

BEAVER WT, 1967, CLIN PHARMACOL THER, V8, P415

[3]

BERKOWITZ B A, 1976, Clinical Pharmacokinetics, V1, P219, DOI 10.2165/00003088-197601030-00004

[4]

ETTINGER DS, 1979, CANCER TREAT REP, V63, P457

[5]

INTURRISI CE, 1972, CLIN PHARMACOL THER, V13, P923

[6]

KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO

[7]

2-L

[8]

OLSEN GD, 1977, CLIN PHARMACOL THER, V21, P147

[9]

SULLIVAN HR, 1975, BIOMED MASS SPECTROM, V2, P197

[10] METHADONE AND ELDERLY [J].

SYMONDS, P .

BRITISH MEDICAL JOURNAL, 1977, 1 (6059) :512-512

← 1 2 →